Type:Notice
Citation:90 FR 11997
Reading Time:about a minute or two
Patheon Pharmaceuticals Inc. has applied to the Drug Enforcement Administration to become a registered bulk manufacturer of certain controlled substances. The company plans to use these substances as Active Pharmaceutical Ingredients in FDA-approved medications. Anybody interested can submit comments or objections electronically by May 12, 2025, through the Federal eRulemaking Portal. Requests for a hearing regarding this application are also due by the same date.
Simple Explanation
Patheon Pharmaceuticals wants permission to make special medicines that need strict rules, and people can say what they think about this plan until May 12, 2025.